1. Tkemaladze, Tinatin, Bratland, Eirik, Bregvadze, Kakha, Houge, Gunnar, Douzgou, Sofia. 2023. MSMO1 deficiency: a potentially partially treatable, ultrarare neurodevelopmental disorder with psoriasiform dermatitis, alopecia and polydactyly. In Clinical dysmorphology, 32, 97-105. doi:10.1097/MCD.0000000000000461. https://pubmed.ncbi.nlm.nih.gov/37195326/
2. Zheng, Guangfei, Wang, Zhuan, Fan, Yuchun, Chen, Su, Jiang, Lihe. 2021. The Clinical Significance and Immunization of MSMO1 in Cervical Squamous Cell Carcinoma Based on Bioinformatics Analysis. In Frontiers in genetics, 12, 705851. doi:10.3389/fgene.2021.705851. https://pubmed.ncbi.nlm.nih.gov/34759952/
3. Zou, Jing, Liu, Sha, Long, Jian. 2024. Up-regulation of MSMO1 was associated with poor survival in cervical cancer. In Translational cancer research, 13, 5316-5327. doi:10.21037/tcr-24-243. https://pubmed.ncbi.nlm.nih.gov/39525016/
4. Wang, Huiqing, Zhao, Mingpei, Chen, Guorong, Kang, Dezhi, Yu, Lianghong. 2024. Identifying MSMO1, ELOVL6, AACS, and CERS2 related to lipid metabolism as biomarkers of Parkinson's disease. In Scientific reports, 14, 17478. doi:10.1038/s41598-024-68585-3. https://pubmed.ncbi.nlm.nih.gov/39080336/
智鼠故事 
